Medtech Insights

The US heart valve device market continues to be driven by the introduction of novel products and key approvals for new indications of existing products. In particular, recent approvals of…

The Latin American neurovascular device market is poised to experience moderate growth through 2034. This growth will be driven by the introduction of newly developed technologies, increasing…

The Latin American TEO device market is poised to experience moderate growth through 2034. This growth will be driven by the introduction of newly developed technologies, increasing adoption of…

Although COVID-19 has negatively impacted the Latin American transcatheter embolization and occlusion device market, the impact of COVID-19 has been limited. The market will expand at a modest rate…

The Asia Pacific TEO device market will experience steady growth over the forecast period, driven by rising cancer incidence, increasing preference for minimally invasive procedures, and clinical…

Expansion of the European dialysis access treatment device market will be driven by the growing ESRD population and increasing demand for maintenance devices. However, cost constraints may continue…

The Asia Pacific dialysis access treatment device market will grow modestly through 2034, driven by the increasing patient population requiring dialysis care and the anticipated launch of devices…

The Asia Pacific aortic repair device market is projected to experience robust growth during the forecast period, fueled by rising endovascular procedure volumes, ongoing innovation in aortic stent…

The US PV device market will be primarily driven by product innovation, novel technologies, and adoption of premium solutions. However, barriers such as the push for cost-effective PV interventions…

The European PV device market will be mainly driven by the increasing availability of premium-priced products and emerging products which, supported by clinical data, will increase the penetration…

The Japanese EP mapping and ablation device market will experience moderate growth through 2034, supported by rising cardiac arrhythmia prevalence, broader treatment accessibility, and ongoing…

The US TEO device market is expected to grow, supported by the approval of new product types within existing indications, entry of new players into different device segments, and favorable changes…